Two Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan

MT Newswires Live

09/03

Two investors agreed to acquire a stake in Fujian Cosunter Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.

The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.

Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.

After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2564636403"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2564636403\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2564636403?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-03 16:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564636403","market":"us","top_or_hot":-1,"title":"Two Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan","media":"MT Newswires Live","content":"<html><body><p> Two investors agreed to acquire a stake in <a href=\"https://laohu8.com/S/300436\">Fujian Cosunter</a> Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.</p><p>The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.</p><p>Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.</p><p>After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Two Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwo Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-09-03 16:08</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Two investors agreed to acquire a stake in <a href=\"https://laohu8.com/S/300436\">Fujian Cosunter</a> Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.</p><p>The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.</p><p>Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.</p><p>After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"醫藥製造","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2564636403","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564636403","pubTimestamp":1756886887,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Two investors agreed to acquire a stake in Fujian Cosunter Pharmaceutical's  unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.Fuzhou Aotai Phase V Investment Partnership  and Fuzhou Aotai Phase VI Investment Partnership  will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300436":"广生堂","BK0239":"医药制造","BK4211":"区域性银行","ISBC":"投资者银行"},"translate_title":"两名投资者以1.91亿元入股福建科森特药业子公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300436":0.9,"ISBC":1},"content_text":"Two investors agreed to acquire a stake in Fujian Cosunter Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}